JSPR

Latest SEC Filings & News for JSPR

4 most recent filings and news items mentioning JSPR. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/JSPR/news?limit=20"

Pull JSPR filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
M&AJul 17, 2026Neutral

Jasper Therapeutics and Kira Pharmaceuticals agree to merge.

Jasper Therapeutics and Kira Pharmaceuticals have entered into a merger agreement. This transaction is intended to combine their oncology capabilities and advance pipeline development.

View filing at SEC.gov →
M&AJul 16, 2026Neutral

Jasper Closes Merger with Kira and Raises $132M

Jasper Therapeutics announced the completion of an all-stock merger with Kira Pharmaceuticals and a concurrent $132 million private placement. This transaction combines pipelines for complement therapies and secures funding to support operations through the second half of 2028.

View filing at SEC.gov →
M&AJun 5, 2026Neutral

Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate

Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate

View filing at SEC.gov →
M&AJun 1, 2026Negative

Jasper Therapeutics explores strategic alternatives including asset sale or wind-down

Jasper Therapeutics initiated a comprehensive review of strategic alternatives to maximize shareholder value, including potential asset sales, licensing, collaborations, company sale, or orderly wind-down. The clinical-stage biotech company is evaluating cost-saving measures whil

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.